Comparison of the inter-laminar approach and laminotomy open approach for filum terminale lipoma: A retrospective analysis
Child's Nervous System · 2024
DOI: 10.1007/s00381-024-06507-4 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Child's Nervous System, 2024. Verfasst von Tomoki Nawashiro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Aichi Children's Health and Medical Center, Obu, Aichi, Japan. Hauptthemen laut MEDLINE: Lipoma, Cauda Equina, Laminectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Aichi Children's Health and Medical Center, Obu, Aichi, Japan.
- Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
- Department of Neurosurgery, Aichi Children's Health and Medical Center, Obu, Aichi, Japan. rythmista@me.com.
- Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL, USA.
Zitieren
APA
Nawashiro, T., Kurimoto, M., Nagakura, M., Kato, M., Aoki, K., & Saito, R. (2024). Comparison of the inter-laminar approach and laminotomy open approach for filum terminale lipoma: A retrospective analysis. Child's Nervous System. https://doi.org/10.1007/s00381-024-06507-4
Vancouver
Nawashiro T, Kurimoto M, Nagakura M, Kato M, Aoki K, Saito R. Comparison of the inter-laminar approach and laminotomy open approach for filum terminale lipoma: A retrospective analysis. Child's Nervous System. 2024. doi:10.1007/s00381-024-06507-4
BibTeX
@article{Nawashiro2024,
author = {Nawashiro, Tomoki and Kurimoto, Michihiro and Nagakura, Masamune and Kato, Mihoko and Aoki, Kousuke and Saito, Ryuta},
title = {Comparison of the inter-laminar approach and laminotomy open approach for filum terminale lipoma: A retrospective analysis},
journal = {Child's Nervous System},
year = {2024},
doi = {10.1007/s00381-024-06507-4}
}
EUVIMED